Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03653429 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Tranexamic Acid in Foot and Ankle Surgeries
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT03653429 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants.
The verdict
NCT03653429, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
Epidemiology of foot and ankle surgeries that present to the hospitals in the US are often underestimated. However there has been growing emphasis on identification of these injuries and practice patterns.
Interventions
- DRUG Normal saline
- DRUG Tranexamic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03653429
The ClinicalTrials.gov registry entry for NCT03653429 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT03653429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03653429 about?
NCT03653429 is a clinical study titled "Efficacy of Tranexamic Acid in Foot and Ankle Surgeries". Epidemiology of foot and ankle surgeries that present to the hospitals in the US are often underestimated. However there has been growing emphasis on identification of these injuries and practice patterns.
What is the current status of trial NCT03653429?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-03-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03653429?
The interventions under investigation include: Normal saline (DRUG), Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT03653429?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.